The Bioinformatics Institute (Abbreviation: BII[1]) is one of the Biomedical Sciences Institutes of the Agency for Science, Technology and Research, (A*STAR). BII was originally founded in 2001 by Dr Rajagopal as a support unit for Bioinformatics and IT service management. However, since August 2007, it has been redefined as a biological research organisation upon the arrival of the current executive director, Dr Frank Eisenhaber. [2]BII focuses on "computationally biology-driven life science research aimed at the discovery of biomolecular mechanisms."[3] BII also develops computer based research tools and performs experimental verifications in its own experimental facilities or by collaborating with appropriate groups.
Agency overview | |
---|---|
Formed | 2001 |
Headquarters | 30 Biopolis Street, #07-01 Matrix, S(138671) |
Agency executive |
|
Parent agency | Agency for Science, Technology and Research |
Website | www |
BII is home to the journal Scientific Phone Apps and Mobile Devices[4] with SpringerNature.
There are currently four research divisions in BII:
- Biomolecular Sequence to Function
- Biomolecular Modelling and Design
- Imaging Informatics
- Translational Research
Under Dr. Sebastian Maurer-Stroh, the team at BII quality-checked genomic sequences uploaded by various countries to the GISAID database that stores and shares COVID-19 virus data.[5]
External links
editReferences
edit- ^ "Bioinformatics Institute". www.bii.a-star.edu.sg. Retrieved 2017-08-03.
- ^ "Bioinformatics Institute".
- ^ "Bioinformatics Institute - Featured on Influenza Initiative" (PDF).
- ^ "Scientific Phone Apps and Mobile Devices". Scientific Phone Apps and Mobile Devices. Retrieved 2017-08-03.
- ^ Khalik, Salma (15 January 2021). "Punching above its weight in global fight against Covid-19". The Straits Times. Retrieved 12 September 2021.